🇺🇸 FDA
Patent

US 8003692

Methods and compositions to inhibit edema factor and adenylyl cyclase

granted A61KA61K31/122A61K31/192

Quick answer

US patent 8003692 (Methods and compositions to inhibit edema factor and adenylyl cyclase) held by The Board of Regents of the University of Texas System expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/122, A61K31/192, A61K31/216, A61K31/34